We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$130M
AUM Growth
+$7.07M
Cap. Flow
+$1.05M
Cap. Flow %
0.81%
Top 10 Hldgs %
34.18%
Holding
91
New
29
Increased
18
Reduced
13
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 36.32%
2 Communication Services 15.71%
3 Industrials 11.23%
4 Consumer Discretionary 10%
5 Materials 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENPH icon
51
Enphase Energy
ENPH
$5.2B
$944K 0.73%
+63,000
New +$798K
EQM
52
DELISTED
EQM Midstream Partners, LP
EQM
$896K 0.69%
10,000
-10,000
-50% -$920K
TRUE
53
DELISTED
TrueCar
TRUE
$889K 0.68%
+49,500
New +$825K
AVDL
54
DELISTED
Avadel Pharmaceuticals
AVDL
$887K 0.68%
62,000
+5,000
+9% +$71.9K
FOLD
55
DELISTED
Amicus Therapeutics
FOLD
$774K 0.6%
+130,000
New +$681K
GRA
56
DELISTED
W.R. Grace & Co.
GRA
$773K 0.59%
+8,500
New +$814K
ATRO icon
57
Astronics
ATRO
$3.51B
$697K 0.54%
26,697
-6,872
-20% -$188K
HQY icon
58
HealthEquity
HQY
$8.72B
$659K 0.51%
+36,000
New +$691K
GOGO icon
59
Gogo Inc
GOGO
$606M
$422K 0.32%
25,000
-40,000
-62% -$682K
JVA icon
60
Coffee Holding Co
JVA
$19.4M
$384K 0.3%
+70,000
New +$446K
KMG
61
DELISTED
KMG Chemicals Inc
KMG
$246K 0.19%
+15,127
New +$253K
ACHN
62
DELISTED
Achillion Pharmaceuticals
ACHN
$200K 0.15%
+20,000
New +$186K
CORV
63
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$127K 0.1%
14,213
-25,087
-64% -$183K
ACAD icon
64
CALL
Acadia Pharmaceuticals
ACAD
$4.39B
$79K 0.06%
3,200
PODD icon
65
Insulet
PODD
$11.8B
$55K 0.04%
+1,500
New +$54.8K
ALNY icon
66
Alnylam Pharmaceuticals
ALNY
$29.5B
-20,000
Closed -$1.26M
ARCT icon
67
Arcturus Therapeutics
ARCT
$171M
-714
Closed -$87K
BHC icon
68
Bausch Health
BHC
$2.62B
-11,500
Closed -$1.45M
IWM icon
69
PUT
iShares Russell 2000 ETF
IWM
$81.5B
-49,800
Closed -$5.92M
JBLU icon
70
JetBlue
JBLU
$2.35B
-100,000
Closed -$1.08M
LYV icon
71
Live Nation Entertainment
LYV
$42.3B
-25,000
Closed -$617K
NRG icon
72
NRG Energy
NRG
$29.2B
-40,000
Closed -$1.49M
QQQ icon
73
PUT
Invesco QQQ Trust
QQQ
$469B
-12,400
Closed -$1.16M
VCYT icon
74
Veracyte
VCYT
$3.58B
-112,500
Closed -$1.93M
VNDA icon
75
Vanda Pharmaceuticals
VNDA
$315M
-44,000
Closed -$712K

Similar funds

Atika Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Atika Capital Management held 91 positions worth $130M, up 5.7% from $123M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management's Q3 2014 filing shows 29 new, 18 increased, 13 reduced and 26 closed positions. Its largest new stake was Advance Auto Parts: 25,000 shares worth $3.26M. The largest sale was INTERMUNE INC, an estimated $4.59M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Communication Services and Industrials.

  • Atika Capital Management's largest Q3 2014 buy was Advance Auto Parts: 25,000 shares worth $3.26M.
  • Atika Capital Management added most to Allergan plc in Q3 2014, an estimated $2.8M increase.
  • Atika Capital Management's biggest Q3 2014 reduction was Shire pic, cutting an estimated $2.75M.
  • Atika Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $4.59M.
  • Atika Capital Management's ten largest holdings make up 34% of its $130M portfolio in Q3 2014.
  • Atika Capital Management opened 29 new positions and closed 26 in Q3 2014.
  • Atika Capital Management's portfolio value rose 5.7% quarter-over-quarter to $130M.

Based on Atika Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.